Source - LSE Regulatory
RNS Number : 4641F
Citigroup Global Markets Limited
16 July 2021
 

 

 

Amendment to section 2(a) & (b)

FORM 38.5(a)

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(a) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITH RECOGNISED INTERMEDIARY STATUS AND DEALING IN A CLIENT-SERVING CAPACITY

 

1.       KEY INFORMATION

 

Name of exempt principal trader

Citigroup Global Markets Limited

Company dealt in

UDG Healthcare plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

€0.05 ordinary shares

Date of dealing

14 July 2021

 

2.        DEALINGS (Note 2)

 

(a)      Purchases and sales

 

Total number of relevant securities acquired

Highest price paid (Note 3)

Lowest price paid

(Note 3)

249,030

GBP 10.7400

GBP 10.7100

 

 

Total number of securities disposed

Highest price received (Note 3)

Lowest price received

(Note 3)

38,991

GBP 10.7400

GBP 10.7100

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 4)

Number of relevant securities

(Note 5)

Price per unit

(Note 3) GBP

TRS

Increasing Short Position

4,639

10.7100

TRS

Increasing Short Position

2,397

10.7200

TRS

Increasing Short Position

52

10.7100

TRS

Increasing Short Position

1,294

10.7350

TRS

Increasing Short Position

1,657

 

10.7300

TRS

Increasing Short Position

200,00

10.7154

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 5)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 3)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 3)

 

 

 

 

 

3.      OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the 

voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition 

or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

 

 

 

 

Date of disclosure

16 July 2021

Contact name

Craig Watson

Telephone number

00 44 (0) 2890409605

Name of offeree/offeror with which connected

Nenelite Limited -   a company controlled by Clayton, Dubilier & Rice, LLC

Nature of connection (Note 6)

Financial Advisor

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ISERFMRTMTABMBB
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJBell logo

Related Charts